🔗 Share this article

An underground market for unlicensed slimming medications is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.

Investigational Drug Gaining Traction Via Social Media

The experimental drug, which remains in research studies, is being promoted by online personalities for its alleged weight-reducing effects. Viewers are encouraged to contact these accounts privately for source information, while also receiving discount codes.

Active Trade on Messaging Platforms

Separately, a robust trade exists on Telegram, where communities with thousands of participants share comparison images, administration instructions and claims of next-day British shipping. Sellers promote the drug there before redirecting customers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Healthcare Experts Voice Concerns

Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unlicensed drug in the UK is worrisome and could result in individuals injecting products of uncertain source.

Some experts stated the demand for retatrutide could be linked to the rising price of licensed weight loss products such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some influencers try to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still violate medicines, advertising, and customer laws, risking fines, prosecution or imprisonment.

Service Response and Material Removal

According to TikTok, the platform has taken down problematic material and banned associated hashtags and query recommendations. The organization said it was committed to maintaining the platform secure and allocating resources in strengthening compliance measures.

Online Trading Activities

Research also found groups with up to 9,000 participants marketing the experimental drug using the platform's integrated search feature, which functions like a online catalog. Entering “retatrutide” instantly brings up groups with thousands of members, populated with photos of slimming results, positive testimonials and detailed instructions for mixing or injecting at home.

After minutes of entering one group, a vendor posted WhatsApp details, where the majority of purchases take place. The seller sent an instruction manual and guaranteed delivery within two days. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about weight, health issues or past usage.

Product Information and Costs

Inside these communities, messages show dark colored packages with Royal Mail labels, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, mixed at home with sterile water, or ready-to-use injectors usually priced at £160 for 20mg. When questioned how much time a pen should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for Telegram said it actively moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are injecting substances they can’t verify. Although the research behind this drug is sound, these online versions may not contain what they advertise,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs increasing, individuals are using social media. But fake injections are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she said.

Her team has already seen patients harmed by self-injection from unconfirmed sources. “We recognize the disappointment, but buying from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A representative from Eli Lilly said retatrutide was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can market [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet approved … may subject patients to potentially significant medical dangers”.